Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Patient Compliance × Lapatinib × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 1 Patient Compliance 1 Neoplasm Metastasis 1 Breast Neoplasms 1

Interventions

Trastuzumab 1 Surveys and Questionnaires 1 N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 1 Lapatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01273610 2025-06-10

Tolerability of the Combination of Lapatinib and Trastuzumab in Adults Age 60 or Older With HER2 Positive Locally Advanced or Metastatic Breast Cancer

City of Hope Medical Center

Phase 2 Active not recruiting

40 enrolled 15 charts

Breast Neoplasms, Patient Compliance

Data powered by HemOnc (CC BY 4.0) Colophon ⚡